跳至主要内容
临床试验/ACTRN12614000201673
ACTRN12614000201673已完成3 期

A Randomised, Double Blind, Placebo Controlled Trial to Assess the Efficacy of Preoperative Oral Vitamin D3 at Preventing Postoperative Hypocalcaemia in Patients Undergoing Total Thyroidectomy.

Hunter New England Local Health District0 个研究点目标入组 160 人开始时间: 2014年2月25日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
160

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Patients undergoing total thyroidectomy for any cause, able to provide written informed consent.
  • Must be able to complete follow-up.

排除标准

  • -Current treatment for vitamin D deficiency at time of assessment with any form of vitamin D supplementation
  • -Chronic kidney disease (eGFR <60)
  • -Need for urgent surgery precluding completion of the intervention course
  • -Known primary parathyroid disease
  • -Pregnancy
  • -Current treatment with bisphosphonates
  • -Known severe liver disease (previous INR >1.4 without anticoagulant treatment in the presence of known liver disease, or Bilirubin > 40 in the presence of obstructive LFT profile )
  • -Hypercalcaemia (>2.55nmol/L) on initial pre-operative blood tests.
  • Refuse or are unable to provide written consent to participate

研究者

相似试验